奥美医疗
(002950)
| 流通市值：37.83亿 | | | 总市值：53.00亿 |
| 流通股本：4.52亿 | | | 总股本：6.33亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 758,656,819.43 | 3,326,292,089.93 | 2,450,075,783.88 | 1,581,653,251.91 |
| 营业收入 | 758,656,819.43 | 3,326,292,089.93 | 2,450,075,783.88 | 1,581,653,251.91 |
| 二、营业总成本 | 659,488,618.5 | 2,873,903,377.52 | 2,139,239,584.07 | 1,362,642,844.11 |
| 营业成本 | 527,146,585.71 | 2,368,862,143.45 | 1,764,294,309.6 | 1,125,827,130 |
| 税金及附加 | 4,469,830.84 | 18,498,272.31 | 15,041,295.36 | 9,678,065.67 |
| 销售费用 | 23,998,289.19 | 95,911,944.91 | 69,736,169.45 | 43,509,401.85 |
| 管理费用 | 74,860,073.5 | 281,930,049.23 | 214,035,448.21 | 135,122,608.62 |
| 研发费用 | 29,820,611.27 | 106,370,339.78 | 57,853,716.21 | 38,807,994.41 |
| 财务费用 | -806,772.01 | 2,330,627.84 | 18,278,645.24 | 9,697,643.56 |
| 其中:利息费用 | 4,856,618.89 | 25,525,930.31 | 21,128,898.88 | 14,794,391.74 |
| 其中:利息收入 | 2,084,624.44 | 7,164,858.07 | 4,874,826.08 | 1,633,981.42 |
| 加:公允价值变动收益 | 4,613,134.1 | -21,906,897.02 | -6,863,365.07 | -6,711,881.64 |
| 加:投资收益 | -974,588.28 | -1,369,487.3 | 3,329,894.02 | 5,525,208.76 |
| 资产处置收益 | 46,472.2 | 28,789,418.21 | -567,521.96 | -567,521.98 |
| 资产减值损失(新) | -2,903,438.16 | -32,813,416.9 | -2,719,113.76 | -458,336.55 |
| 信用减值损失(新) | 1,575,844.66 | -3,054,803.11 | -1,830,662.78 | -2,121,523.71 |
| 其他收益 | 11,120,961.92 | 36,431,206.55 | 29,167,044.75 | 21,793,317.78 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 112,646,587.37 | 458,464,732.84 | 331,352,475.01 | 236,469,670.46 |
| 加:营业外收入 | 18,136.54 | 2,051,015.01 | 1,603,712.69 | 1,047,558.69 |
| 减:营业外支出 | 1,042,744.56 | 6,124,486.99 | 2,449,751.12 | 2,333,319.94 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 111,621,979.35 | 454,391,260.86 | 330,506,436.58 | 235,183,909.21 |
| 减:所得税费用 | 24,969,103.69 | 85,594,588.75 | 64,822,658.6 | 47,901,376.54 |
| 六、净利润 | 86,652,875.66 | 368,796,672.11 | 265,683,777.98 | 187,282,532.67 |
| 持续经营净利润 | 86,652,875.66 | 368,796,672.11 | 265,683,777.98 | 187,282,532.67 |
| 归属于母公司股东的净利润 | 86,502,742.68 | 368,679,147.09 | 265,165,311.97 | 186,996,628.29 |
| 少数股东损益 | 150,132.98 | 117,525.02 | 518,466.01 | 285,904.38 |
| (一)基本每股收益 | 0.14 | 0.59 | 0.42 | 0.3 |
| (二)稀释每股收益 | 0.14 | 0.59 | 0.42 | 0.3 |
| 八、其他综合收益 | 651,010.9 | -19,137,263.29 | -2,256,425.56 | -5,341,092.58 |
| 归属于母公司股东的其他综合收益 | 651,010.9 | -19,137,263.29 | -2,256,425.56 | -5,341,092.58 |
| 九、综合收益总额 | 87,303,886.56 | 349,659,408.82 | 263,427,352.42 | 181,941,440.09 |
| 归属于母公司股东的综合收益总额 | 87,153,753.58 | 349,541,883.8 | 262,908,886.41 | 181,655,535.71 |
| 归属于少数股东的综合收益总额 | 150,132.98 | 117,525.02 | 518,466.01 | 285,904.38 |
| 公告日期 | 2025-04-26 | 2025-04-26 | 2024-10-31 | 2024-08-31 |
| 审计意见(境内) | | 标准无保留意见 | | |